Posted: Tuesday, February 1, 2022
Joe Schroers-Martin, MD, of Stanford University, talks about what led to the hypothesis and subsequent study findings that markers for follicular lymphoma may be detectable long before the disease is diagnosed and how this knowledge might be used in the clinic.